Detalhe da pesquisa
1.
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes.
N Engl J Med
; 390(15): 1394-1407, 2024 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587233
2.
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.
N Engl J Med
; 389(12): 1069-1084, 2023 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37622681
3.
Effect of Dapagliflozin Versus Placebo on Symptoms and 6-Minute Walk Distance in Patients With Heart Failure: The DETERMINE Randomized Clinical Trials.
Circulation
; 149(11): 825-838, 2024 03 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38059368
4.
Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial.
Circulation
; 149(3): 204-216, 2024 01 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37952180
5.
The Urban Environment and Cardiometabolic Health.
Circulation
; 149(16): 1298-1314, 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38620080
6.
Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials.
Lancet
; 403(10437): 1635-1648, 2024 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38599221
7.
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.
N Engl J Med
; 387(12): 1089-1098, 2022 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36027570
8.
Semaglutide and Diuretic Use in Obesity-Related Heart Failure with Preserved Ejection Fraction: A Pooled Analysis of the STEP-HFpEF and STEP-HFpEF-DM trials.
Eur Heart J
; 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38739118
9.
Racial Differences in Quality of Life in Patients With Heart Failure Treated With Sodium-Glucose Cotransporter 2 Inhibitors: A Patient-Level Meta-Analysis of the CHIEF-HF, DEFINE-HF, and PRESERVED-HF Trials.
Circulation
; 148(3): 220-228, 2023 07 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37191040
10.
Endothelin-1, Outcomes in Patients With Heart Failure and Reduced Ejection Fraction, and Effects of Dapagliflozin: Findings From DAPA-HF.
Circulation
; 147(22): 1670-1683, 2023 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37039015
11.
Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial.
Circulation
; 148(22): 1735-1745, 2023 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37632455
12.
Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial.
Circulation
; 148(24): 1945-1957, 2023 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37830208
13.
Patient Characteristics, Outcomes, and Effects of Dapagliflozin According to the Duration of Heart Failure: A Prespecified Analysis of the DELIVER Trial.
Circulation
; 147(14): 1067-1078, 2023 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36876483
14.
Effect of the P-Selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled Trial.
Circulation
; 148(5): 381-390, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37356038
15.
Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVER.
Circulation
; 147(8): 624-634, 2023 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36342789
16.
Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial.
Circulation
; 147(4): 284-295, 2023 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36335517
17.
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association.
Circulation
; 148(20): 1636-1664, 2023 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37807920
18.
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association.
Circulation
; 148(20): 1606-1635, 2023 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37807924
19.
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.
N Engl J Med
; 384(2): 129-139, 2021 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33200891
20.
Aldosterone and aldosterone synthase inhibitors in cardiorenal disease.
Am J Physiol Heart Circ Physiol
; 326(3): H670-H688, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38133623